Project
PRJNA375882: Comprehensive Mouse Transcriptomic BodyMap
Navigation
Downloads
Results for Ybx1_Nfya_Nfyb_Nfyc_Cebpz
Z-value: 4.73
Motif logo
Transcription factors associated with Ybx1_Nfya_Nfyb_Nfyc_Cebpz
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
Ybx1
|
ENSMUSG00000028639.15 | Ybx1 |
|
Nfya
|
ENSMUSG00000023994.14 | Nfya |
|
Nfyb
|
ENSMUSG00000020248.19 | Nfyb |
|
Nfyc
|
ENSMUSG00000032897.18 | Nfyc |
|
Cebpz
|
ENSMUSG00000024081.10 | Cebpz |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| Nfya | mm39_v1_chr17_-_48716756_48716934 | 0.62 | 4.5e-09 | Click! |
| Cebpz | mm39_v1_chr17_-_79244460_79244504 | 0.48 | 2.2e-05 | Click! |
| Nfyb | mm39_v1_chr10_-_82599967_82599991 | 0.47 | 2.6e-05 | Click! |
| Ybx1 | mm39_v1_chr4_-_119151717_119151801 | 0.43 | 1.6e-04 | Click! |
| Nfyc | mm39_v1_chr4_-_120672900_120672959 | 0.36 | 1.7e-03 | Click! |
Activity profile of Ybx1_Nfya_Nfyb_Nfyc_Cebpz motif
Sorted Z-values of Ybx1_Nfya_Nfyb_Nfyc_Cebpz motif
Network of associatons between targets according to the STRING database.
First level regulatory network of Ybx1_Nfya_Nfyb_Nfyc_Cebpz
Gene Ontology Analysis
Gene overrepresentation in biological process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 11.5 | 34.5 | GO:0032877 | positive regulation of DNA endoreduplication(GO:0032877) |
| 10.5 | 52.5 | GO:0045091 | regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) |
| 7.7 | 77.2 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
| 7.4 | 22.3 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
| 7.3 | 21.8 | GO:1904761 | negative regulation of myofibroblast differentiation(GO:1904761) |
| 7.0 | 21.0 | GO:1902299 | pre-replicative complex assembly involved in nuclear cell cycle DNA replication(GO:0006267) pre-replicative complex assembly(GO:0036388) DNA replication preinitiation complex assembly(GO:0071163) pre-replicative complex assembly involved in cell cycle DNA replication(GO:1902299) |
| 6.9 | 20.7 | GO:1901994 | negative regulation of meiotic cell cycle phase transition(GO:1901994) |
| 6.5 | 52.3 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
| 6.4 | 19.3 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
| 5.9 | 64.7 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 5.9 | 123.4 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
| 5.0 | 24.8 | GO:0098763 | mitotic cell cycle phase(GO:0098763) |
| 4.6 | 41.4 | GO:0090166 | Golgi disassembly(GO:0090166) |
| 4.4 | 13.3 | GO:1903406 | regulation of sodium:potassium-exchanging ATPase activity(GO:1903406) |
| 4.3 | 13.0 | GO:0043973 | histone H3-K4 acetylation(GO:0043973) |
| 4.3 | 42.9 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
| 4.2 | 20.8 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
| 3.6 | 21.5 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
| 3.5 | 10.6 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
| 3.5 | 10.4 | GO:2000417 | negative regulation of integrin activation(GO:0033624) regulation of matrix metallopeptidase secretion(GO:1904464) matrix metallopeptidase secretion(GO:1990773) positive regulation of ovarian follicle development(GO:2000386) regulation of antral ovarian follicle growth(GO:2000387) positive regulation of antral ovarian follicle growth(GO:2000388) negative regulation of eosinophil migration(GO:2000417) |
| 3.5 | 10.4 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
| 3.5 | 17.3 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
| 3.4 | 17.0 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
| 3.3 | 9.9 | GO:0090367 | negative regulation of mRNA modification(GO:0090367) |
| 3.3 | 42.9 | GO:0010826 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
| 3.3 | 16.4 | GO:0051754 | meiotic sister chromatid cohesion, centromeric(GO:0051754) |
| 3.2 | 9.7 | GO:0070194 | synaptonemal complex disassembly(GO:0070194) |
| 3.0 | 9.1 | GO:1904826 | regulation of hydrogen sulfide biosynthetic process(GO:1904826) positive regulation of hydrogen sulfide biosynthetic process(GO:1904828) |
| 3.0 | 12.1 | GO:1901675 | negative regulation of histone H3-K27 acetylation(GO:1901675) |
| 3.0 | 14.8 | GO:0031509 | telomeric heterochromatin assembly(GO:0031509) negative regulation of chromosome condensation(GO:1902340) |
| 2.9 | 11.5 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
| 2.8 | 31.3 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
| 2.8 | 19.9 | GO:0000733 | DNA strand renaturation(GO:0000733) |
| 2.8 | 11.2 | GO:0006272 | leading strand elongation(GO:0006272) |
| 2.8 | 11.1 | GO:0033140 | negative regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033140) |
| 2.6 | 44.7 | GO:0090308 | regulation of methylation-dependent chromatin silencing(GO:0090308) |
| 2.5 | 12.6 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
| 2.5 | 5.0 | GO:0044837 | assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
| 2.5 | 82.3 | GO:0006270 | DNA replication initiation(GO:0006270) |
| 2.5 | 14.9 | GO:1903755 | regulation of SUMO transferase activity(GO:1903182) positive regulation of SUMO transferase activity(GO:1903755) |
| 2.4 | 12.0 | GO:0035740 | CD8-positive, alpha-beta T cell proliferation(GO:0035740) regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000564) |
| 2.4 | 7.2 | GO:0002270 | plasmacytoid dendritic cell activation(GO:0002270) |
| 2.4 | 30.8 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
| 2.4 | 7.1 | GO:1901074 | regulation of engulfment of apoptotic cell(GO:1901074) |
| 2.3 | 11.7 | GO:0000973 | posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
| 2.3 | 23.3 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
| 2.3 | 16.2 | GO:0010993 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
| 2.3 | 27.6 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
| 2.3 | 6.8 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
| 2.3 | 13.6 | GO:0034080 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
| 2.3 | 4.5 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
| 2.2 | 13.4 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
| 2.2 | 4.5 | GO:0016321 | female meiosis chromosome segregation(GO:0016321) |
| 2.2 | 6.6 | GO:0034240 | negative regulation of macrophage fusion(GO:0034240) |
| 2.2 | 8.8 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
| 2.1 | 42.7 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
| 2.1 | 27.8 | GO:0051310 | metaphase plate congression(GO:0051310) |
| 2.1 | 6.3 | GO:0002343 | peripheral B cell selection(GO:0002343) B cell affinity maturation(GO:0002344) |
| 2.1 | 6.3 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
| 2.1 | 33.2 | GO:0034770 | histone H4-K20 methylation(GO:0034770) |
| 2.1 | 8.3 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
| 2.0 | 6.1 | GO:0060734 | regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:0060734) |
| 2.0 | 4.0 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
| 2.0 | 18.0 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
| 2.0 | 2.0 | GO:0051595 | response to methylglyoxal(GO:0051595) |
| 2.0 | 6.0 | GO:0072312 | metanephric glomerular visceral epithelial cell differentiation(GO:0072248) metanephric glomerular visceral epithelial cell development(GO:0072249) metanephric glomerular epithelial cell differentiation(GO:0072312) metanephric glomerular epithelial cell development(GO:0072313) |
| 2.0 | 6.0 | GO:0097694 | establishment of RNA localization to telomere(GO:0097694) |
| 2.0 | 7.9 | GO:0046898 | response to cycloheximide(GO:0046898) |
| 1.9 | 17.4 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
| 1.9 | 3.9 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
| 1.9 | 34.3 | GO:0033280 | response to vitamin D(GO:0033280) |
| 1.9 | 3.8 | GO:0072708 | response to sorbitol(GO:0072708) |
| 1.9 | 5.6 | GO:0071707 | immunoglobulin heavy chain V-D-J recombination(GO:0071707) |
| 1.9 | 7.5 | GO:0090579 | transcriptional activation by promoter-enhancer looping(GO:0071733) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
| 1.9 | 22.3 | GO:0033504 | floor plate development(GO:0033504) |
| 1.8 | 5.5 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
| 1.8 | 16.4 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
| 1.8 | 3.6 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
| 1.8 | 19.8 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
| 1.8 | 10.8 | GO:0071459 | protein localization to chromosome, centromeric region(GO:0071459) |
| 1.8 | 9.0 | GO:0031022 | nuclear migration along microfilament(GO:0031022) |
| 1.8 | 8.9 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
| 1.8 | 5.3 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
| 1.7 | 80.1 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
| 1.7 | 5.1 | GO:0070376 | regulation of ERK5 cascade(GO:0070376) |
| 1.7 | 5.0 | GO:0098974 | postsynaptic actin cytoskeleton organization(GO:0098974) |
| 1.6 | 8.2 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
| 1.6 | 3.2 | GO:1990918 | double-strand break repair involved in meiotic recombination(GO:1990918) |
| 1.6 | 28.7 | GO:0043486 | histone exchange(GO:0043486) |
| 1.6 | 6.4 | GO:0050822 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent(GO:0002479) peptide stabilization(GO:0050822) peptide antigen stabilization(GO:0050823) |
| 1.6 | 4.7 | GO:2000410 | regulation of thymocyte migration(GO:2000410) |
| 1.6 | 9.4 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) |
| 1.6 | 3.1 | GO:0034508 | centromere complex assembly(GO:0034508) |
| 1.6 | 9.3 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
| 1.5 | 15.4 | GO:0000212 | meiotic spindle organization(GO:0000212) |
| 1.5 | 12.3 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
| 1.5 | 4.6 | GO:0097065 | anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
| 1.5 | 4.5 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
| 1.5 | 4.5 | GO:1990751 | regulation of Schwann cell chemotaxis(GO:1904266) positive regulation of Schwann cell chemotaxis(GO:1904268) Schwann cell chemotaxis(GO:1990751) |
| 1.5 | 7.4 | GO:0002901 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
| 1.5 | 7.3 | GO:0035825 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
| 1.5 | 14.7 | GO:0031507 | heterochromatin assembly(GO:0031507) |
| 1.5 | 7.3 | GO:0002484 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
| 1.5 | 21.8 | GO:0019985 | translesion synthesis(GO:0019985) |
| 1.4 | 7.2 | GO:0035905 | ascending aorta development(GO:0035905) ascending aorta morphogenesis(GO:0035910) |
| 1.4 | 4.2 | GO:0097037 | heme export(GO:0097037) |
| 1.4 | 9.8 | GO:0060266 | negative regulation of respiratory burst involved in inflammatory response(GO:0060266) |
| 1.4 | 4.1 | GO:0048817 | negative regulation of hair follicle maturation(GO:0048817) |
| 1.3 | 5.3 | GO:1905077 | negative regulation of interleukin-17 secretion(GO:1905077) |
| 1.3 | 14.7 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 1.3 | 1.3 | GO:0000349 | generation of catalytic spliceosome for first transesterification step(GO:0000349) |
| 1.3 | 9.2 | GO:0089700 | protein kinase D signaling(GO:0089700) |
| 1.3 | 6.6 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
| 1.3 | 7.7 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
| 1.3 | 21.7 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
| 1.3 | 3.8 | GO:0070476 | rRNA (guanine-N7)-methylation(GO:0070476) |
| 1.3 | 5.1 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
| 1.3 | 7.6 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
| 1.3 | 11.4 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
| 1.3 | 1.3 | GO:0071630 | nucleus-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071630) |
| 1.3 | 2.5 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
| 1.2 | 5.0 | GO:1900224 | positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) |
| 1.2 | 38.0 | GO:0045648 | positive regulation of erythrocyte differentiation(GO:0045648) |
| 1.2 | 14.7 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) |
| 1.2 | 51.3 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
| 1.2 | 8.5 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 1.2 | 7.3 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
| 1.2 | 7.1 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
| 1.2 | 3.5 | GO:1905223 | epicardium morphogenesis(GO:1905223) |
| 1.2 | 3.5 | GO:0016131 | brassinosteroid metabolic process(GO:0016131) brassinosteroid biosynthetic process(GO:0016132) |
| 1.2 | 3.5 | GO:2001034 | positive regulation of double-strand break repair via nonhomologous end joining(GO:2001034) |
| 1.2 | 15.2 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
| 1.2 | 10.5 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
| 1.2 | 5.8 | GO:0021776 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
| 1.2 | 3.5 | GO:0006336 | DNA replication-independent nucleosome assembly(GO:0006336) |
| 1.2 | 1.2 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
| 1.1 | 11.5 | GO:0044806 | G-quadruplex DNA unwinding(GO:0044806) |
| 1.1 | 3.4 | GO:0060061 | Spemann organizer formation(GO:0060061) |
| 1.1 | 11.5 | GO:0045002 | double-strand break repair via single-strand annealing(GO:0045002) |
| 1.1 | 3.4 | GO:0046901 | tetrahydrofolylpolyglutamate biosynthetic process(GO:0046901) |
| 1.1 | 25.0 | GO:0034587 | piRNA metabolic process(GO:0034587) |
| 1.1 | 3.4 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
| 1.1 | 9.0 | GO:2000781 | positive regulation of double-strand break repair(GO:2000781) |
| 1.1 | 21.1 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
| 1.1 | 4.5 | GO:0002302 | CD8-positive, alpha-beta T cell differentiation involved in immune response(GO:0002302) |
| 1.1 | 9.9 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
| 1.1 | 4.4 | GO:0097343 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
| 1.1 | 13.0 | GO:0046645 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
| 1.1 | 18.4 | GO:0045199 | maintenance of epithelial cell apical/basal polarity(GO:0045199) |
| 1.1 | 10.8 | GO:0021506 | anterior neuropore closure(GO:0021506) neuropore closure(GO:0021995) |
| 1.1 | 5.3 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
| 1.1 | 3.2 | GO:0031125 | rRNA 3'-end processing(GO:0031125) |
| 1.1 | 3.2 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
| 1.0 | 8.3 | GO:0033277 | abortive mitotic cell cycle(GO:0033277) |
| 1.0 | 11.2 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
| 1.0 | 11.2 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
| 1.0 | 1.0 | GO:0060557 | positive regulation of vitamin metabolic process(GO:0046136) positive regulation of vitamin D biosynthetic process(GO:0060557) positive regulation of calcidiol 1-monooxygenase activity(GO:0060559) |
| 1.0 | 3.0 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
| 1.0 | 4.0 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
| 1.0 | 7.0 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
| 1.0 | 8.8 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
| 1.0 | 2.9 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
| 1.0 | 7.7 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
| 1.0 | 2.9 | GO:0034118 | erythrocyte aggregation(GO:0034117) regulation of erythrocyte aggregation(GO:0034118) |
| 1.0 | 6.7 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
| 1.0 | 4.8 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
| 0.9 | 2.8 | GO:1903721 | regulation of I-kappaB phosphorylation(GO:1903719) positive regulation of I-kappaB phosphorylation(GO:1903721) |
| 0.9 | 7.5 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
| 0.9 | 2.8 | GO:0032055 | negative regulation of translation in response to stress(GO:0032055) |
| 0.9 | 15.8 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
| 0.9 | 7.4 | GO:0006868 | glutamine transport(GO:0006868) |
| 0.9 | 3.7 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
| 0.9 | 18.4 | GO:0070986 | left/right axis specification(GO:0070986) |
| 0.9 | 0.9 | GO:0007135 | meiosis II(GO:0007135) |
| 0.9 | 48.5 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
| 0.9 | 9.1 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
| 0.9 | 7.2 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
| 0.9 | 3.6 | GO:0002326 | B cell lineage commitment(GO:0002326) |
| 0.9 | 16.2 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
| 0.9 | 3.6 | GO:0097298 | regulation of nucleus size(GO:0097298) |
| 0.9 | 4.5 | GO:0002266 | follicular dendritic cell activation(GO:0002266) follicular dendritic cell differentiation(GO:0002268) |
| 0.9 | 8.9 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
| 0.9 | 8.8 | GO:0006271 | DNA strand elongation involved in DNA replication(GO:0006271) |
| 0.9 | 3.5 | GO:1900060 | negative regulation of ceramide biosynthetic process(GO:1900060) |
| 0.9 | 13.0 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
| 0.9 | 3.4 | GO:2000196 | positive regulation of female gonad development(GO:2000196) |
| 0.8 | 2.5 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
| 0.8 | 16.9 | GO:0006298 | mismatch repair(GO:0006298) |
| 0.8 | 2.5 | GO:0032510 | endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
| 0.8 | 4.2 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
| 0.8 | 50.2 | GO:0000070 | mitotic sister chromatid segregation(GO:0000070) |
| 0.8 | 8.3 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
| 0.8 | 3.3 | GO:1902303 | negative regulation of potassium ion export(GO:1902303) |
| 0.8 | 18.1 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
| 0.8 | 4.1 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
| 0.8 | 9.6 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
| 0.8 | 4.0 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
| 0.8 | 2.4 | GO:0018160 | peptidyl-pyrromethane cofactor linkage(GO:0018160) |
| 0.8 | 10.4 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.8 | 9.5 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
| 0.8 | 3.1 | GO:0051466 | positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
| 0.8 | 3.9 | GO:0098971 | anterograde dendritic transport of neurotransmitter receptor complex(GO:0098971) |
| 0.8 | 11.6 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
| 0.7 | 3.7 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
| 0.7 | 1.5 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
| 0.7 | 7.4 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
| 0.7 | 17.9 | GO:0048255 | mRNA stabilization(GO:0048255) |
| 0.7 | 4.9 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
| 0.7 | 14.0 | GO:0007099 | centriole replication(GO:0007099) |
| 0.7 | 2.8 | GO:0016062 | adaptation of rhodopsin mediated signaling(GO:0016062) light adaption(GO:0036367) |
| 0.7 | 7.0 | GO:0014029 | neural crest formation(GO:0014029) |
| 0.7 | 2.8 | GO:1904245 | regulation of polynucleotide adenylyltransferase activity(GO:1904245) positive regulation of polynucleotide adenylyltransferase activity(GO:1904247) |
| 0.7 | 112.2 | GO:0007059 | chromosome segregation(GO:0007059) |
| 0.7 | 4.8 | GO:0071028 | nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
| 0.7 | 1.4 | GO:0098749 | cerebellar neuron development(GO:0098749) |
| 0.7 | 2.7 | GO:0044805 | late nucleophagy(GO:0044805) |
| 0.7 | 2.7 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 0.7 | 2.7 | GO:1904378 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
| 0.7 | 2.0 | GO:0032416 | negative regulation of sodium:proton antiporter activity(GO:0032416) |
| 0.7 | 0.7 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
| 0.7 | 6.5 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
| 0.6 | 0.6 | GO:0072368 | regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter(GO:0072368) |
| 0.6 | 1.9 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
| 0.6 | 0.6 | GO:0045204 | MAPK export from nucleus(GO:0045204) |
| 0.6 | 1.3 | GO:0072592 | oxygen metabolic process(GO:0072592) |
| 0.6 | 7.6 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
| 0.6 | 3.2 | GO:0050902 | leukocyte adhesive activation(GO:0050902) |
| 0.6 | 1.3 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
| 0.6 | 5.6 | GO:1900034 | regulation of cellular response to heat(GO:1900034) |
| 0.6 | 15.4 | GO:0043968 | histone H2A acetylation(GO:0043968) |
| 0.6 | 4.2 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
| 0.6 | 9.0 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.6 | 2.4 | GO:1904502 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
| 0.6 | 1.8 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
| 0.6 | 2.3 | GO:0055011 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
| 0.6 | 3.5 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
| 0.6 | 3.5 | GO:0021747 | cochlear nucleus development(GO:0021747) |
| 0.6 | 1.1 | GO:2001200 | positive regulation of dendritic cell differentiation(GO:2001200) |
| 0.6 | 4.0 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
| 0.6 | 2.8 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
| 0.6 | 2.3 | GO:0002752 | leukocyte chemotaxis involved in inflammatory response(GO:0002232) cell surface pattern recognition receptor signaling pathway(GO:0002752) positive regulation of acute inflammatory response to non-antigenic stimulus(GO:0002879) |
| 0.6 | 1.7 | GO:0001788 | antibody-dependent cellular cytotoxicity(GO:0001788) |
| 0.6 | 1.7 | GO:0016584 | nucleosome positioning(GO:0016584) |
| 0.6 | 0.6 | GO:1904528 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) positive regulation of microtubule binding(GO:1904528) |
| 0.6 | 3.9 | GO:0045716 | positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
| 0.6 | 3.3 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
| 0.6 | 12.7 | GO:0001675 | acrosome assembly(GO:0001675) |
| 0.5 | 2.2 | GO:0014916 | regulation of lung blood pressure(GO:0014916) |
| 0.5 | 10.3 | GO:0070995 | NADPH oxidation(GO:0070995) |
| 0.5 | 1.6 | GO:2000422 | T-helper 1 cell lineage commitment(GO:0002296) regulation of eosinophil chemotaxis(GO:2000422) positive regulation of eosinophil chemotaxis(GO:2000424) |
| 0.5 | 7.3 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.5 | 1.6 | GO:0007144 | female meiosis I(GO:0007144) |
| 0.5 | 0.5 | GO:0018312 | peptidyl-serine ADP-ribosylation(GO:0018312) |
| 0.5 | 3.1 | GO:0031120 | snRNA pseudouridine synthesis(GO:0031120) |
| 0.5 | 4.1 | GO:1902951 | negative regulation of dendritic spine maintenance(GO:1902951) |
| 0.5 | 1.0 | GO:2000612 | regulation of thyroid-stimulating hormone secretion(GO:2000612) |
| 0.5 | 3.5 | GO:0007141 | male meiosis I(GO:0007141) |
| 0.5 | 5.0 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
| 0.5 | 3.5 | GO:0070495 | regulation of thrombin receptor signaling pathway(GO:0070494) negative regulation of thrombin receptor signaling pathway(GO:0070495) |
| 0.5 | 1.5 | GO:1903588 | negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
| 0.5 | 6.9 | GO:0080009 | mRNA methylation(GO:0080009) |
| 0.5 | 2.4 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
| 0.5 | 9.7 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
| 0.5 | 1.9 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
| 0.5 | 4.8 | GO:0090487 | toxin catabolic process(GO:0009407) secondary metabolite catabolic process(GO:0090487) |
| 0.5 | 3.4 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
| 0.5 | 1.9 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
| 0.5 | 4.2 | GO:0060137 | maternal process involved in parturition(GO:0060137) |
| 0.5 | 5.6 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
| 0.5 | 3.7 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
| 0.5 | 9.2 | GO:1901991 | negative regulation of mitotic cell cycle phase transition(GO:1901991) |
| 0.5 | 3.2 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
| 0.4 | 0.4 | GO:0007509 | mesoderm migration involved in gastrulation(GO:0007509) |
| 0.4 | 4.8 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
| 0.4 | 0.4 | GO:0019264 | glycine biosynthetic process from serine(GO:0019264) |
| 0.4 | 2.6 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
| 0.4 | 14.5 | GO:0008156 | negative regulation of DNA replication(GO:0008156) |
| 0.4 | 3.9 | GO:0071455 | cellular response to hyperoxia(GO:0071455) |
| 0.4 | 4.7 | GO:2000298 | regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
| 0.4 | 1.7 | GO:0014063 | negative regulation of serotonin secretion(GO:0014063) |
| 0.4 | 15.0 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
| 0.4 | 7.1 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
| 0.4 | 1.2 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
| 0.4 | 2.0 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
| 0.4 | 1.2 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
| 0.4 | 19.8 | GO:0043029 | T cell homeostasis(GO:0043029) |
| 0.4 | 0.8 | GO:0006172 | ADP biosynthetic process(GO:0006172) purine nucleoside diphosphate biosynthetic process(GO:0009136) purine ribonucleoside diphosphate biosynthetic process(GO:0009180) |
| 0.4 | 6.0 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
| 0.4 | 6.0 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
| 0.4 | 78.0 | GO:0044843 | cell cycle G1/S phase transition(GO:0044843) |
| 0.4 | 2.4 | GO:0036337 | Fas signaling pathway(GO:0036337) |
| 0.4 | 7.2 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
| 0.4 | 9.1 | GO:0010592 | positive regulation of lamellipodium assembly(GO:0010592) |
| 0.4 | 6.7 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
| 0.4 | 1.6 | GO:0042663 | regulation of endodermal cell fate specification(GO:0042663) |
| 0.4 | 1.6 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
| 0.4 | 3.9 | GO:0010804 | negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
| 0.4 | 6.2 | GO:0016180 | snRNA processing(GO:0016180) |
| 0.4 | 2.3 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
| 0.4 | 0.8 | GO:0060434 | bronchus morphogenesis(GO:0060434) |
| 0.4 | 0.4 | GO:2000974 | negative regulation of pro-B cell differentiation(GO:2000974) |
| 0.4 | 1.9 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
| 0.4 | 3.0 | GO:0016556 | mRNA modification(GO:0016556) |
| 0.4 | 1.1 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 0.4 | 3.0 | GO:0031297 | replication fork processing(GO:0031297) |
| 0.4 | 1.5 | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
| 0.4 | 0.4 | GO:0010767 | regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage(GO:0010767) |
| 0.4 | 1.8 | GO:0036135 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
| 0.4 | 2.6 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
| 0.4 | 10.2 | GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
| 0.4 | 1.1 | GO:0070175 | positive regulation of enamel mineralization(GO:0070175) |
| 0.4 | 1.8 | GO:0044030 | regulation of DNA methylation(GO:0044030) |
| 0.4 | 3.2 | GO:0046208 | spermine catabolic process(GO:0046208) |
| 0.4 | 6.0 | GO:0008340 | determination of adult lifespan(GO:0008340) |
| 0.4 | 3.2 | GO:0006301 | postreplication repair(GO:0006301) |
| 0.3 | 2.4 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
| 0.3 | 3.8 | GO:1990118 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
| 0.3 | 2.1 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
| 0.3 | 5.0 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
| 0.3 | 0.7 | GO:0007386 | compartment pattern specification(GO:0007386) |
| 0.3 | 0.7 | GO:0072107 | regulation of ureteric bud formation(GO:0072106) positive regulation of ureteric bud formation(GO:0072107) |
| 0.3 | 15.4 | GO:0006376 | mRNA splice site selection(GO:0006376) |
| 0.3 | 2.9 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
| 0.3 | 1.0 | GO:0039526 | suppression by virus of host apoptotic process(GO:0019050) modulation by virus of host apoptotic process(GO:0039526) cellular process regulating host cell cycle in response to virus(GO:0060154) |
| 0.3 | 2.6 | GO:0060017 | parathyroid gland development(GO:0060017) |
| 0.3 | 1.3 | GO:0021691 | cerebellar Purkinje cell layer maturation(GO:0021691) |
| 0.3 | 5.8 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
| 0.3 | 1.9 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) |
| 0.3 | 5.4 | GO:0006972 | hyperosmotic response(GO:0006972) |
| 0.3 | 0.9 | GO:0035523 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
| 0.3 | 1.3 | GO:0010519 | negative regulation of phospholipase activity(GO:0010519) |
| 0.3 | 2.5 | GO:1903564 | regulation of protein localization to cilium(GO:1903564) |
| 0.3 | 31.0 | GO:0051028 | mRNA transport(GO:0051028) |
| 0.3 | 3.4 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
| 0.3 | 7.4 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
| 0.3 | 1.9 | GO:0006543 | glutamine catabolic process(GO:0006543) |
| 0.3 | 5.2 | GO:0071166 | ribonucleoprotein complex localization(GO:0071166) |
| 0.3 | 2.1 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
| 0.3 | 0.9 | GO:0035702 | monocyte homeostasis(GO:0035702) |
| 0.3 | 2.1 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
| 0.3 | 1.2 | GO:0072737 | response to diamide(GO:0072737) cellular response to diamide(GO:0072738) cellular response to sodium arsenite(GO:1903936) |
| 0.3 | 1.7 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
| 0.3 | 7.9 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
| 0.3 | 3.9 | GO:0010165 | response to X-ray(GO:0010165) |
| 0.3 | 1.1 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
| 0.3 | 5.5 | GO:0015701 | bicarbonate transport(GO:0015701) |
| 0.3 | 1.4 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
| 0.3 | 2.8 | GO:0040034 | regulation of development, heterochronic(GO:0040034) |
| 0.3 | 2.2 | GO:0070734 | histone H3-K27 methylation(GO:0070734) |
| 0.3 | 6.2 | GO:0006284 | base-excision repair(GO:0006284) |
| 0.3 | 0.8 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
| 0.3 | 2.4 | GO:0043249 | erythrocyte maturation(GO:0043249) |
| 0.3 | 2.1 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
| 0.3 | 2.6 | GO:0035608 | protein deglutamylation(GO:0035608) |
| 0.3 | 0.5 | GO:0032202 | telomere assembly(GO:0032202) |
| 0.3 | 1.5 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
| 0.3 | 0.3 | GO:0002663 | B cell tolerance induction(GO:0002514) regulation of B cell tolerance induction(GO:0002661) positive regulation of B cell tolerance induction(GO:0002663) |
| 0.3 | 2.1 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
| 0.3 | 2.6 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
| 0.3 | 4.8 | GO:0021983 | pituitary gland development(GO:0021983) |
| 0.3 | 10.4 | GO:0006611 | protein export from nucleus(GO:0006611) |
| 0.3 | 1.3 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
| 0.2 | 0.2 | GO:0045003 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
| 0.2 | 6.7 | GO:0016925 | protein sumoylation(GO:0016925) |
| 0.2 | 1.5 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
| 0.2 | 0.7 | GO:0001983 | baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
| 0.2 | 1.7 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
| 0.2 | 0.7 | GO:0060676 | ureteric bud formation(GO:0060676) |
| 0.2 | 0.7 | GO:0060821 | inactivation of X chromosome by DNA methylation(GO:0060821) |
| 0.2 | 0.7 | GO:1904092 | regulation of autophagic cell death(GO:1904092) negative regulation of autophagic cell death(GO:1904093) |
| 0.2 | 2.1 | GO:0002669 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
| 0.2 | 0.9 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 0.2 | 1.6 | GO:1903232 | melanosome assembly(GO:1903232) |
| 0.2 | 1.2 | GO:0045925 | positive regulation of female receptivity(GO:0045925) |
| 0.2 | 0.9 | GO:0015744 | succinate transport(GO:0015744) |
| 0.2 | 5.5 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
| 0.2 | 8.2 | GO:0031570 | DNA integrity checkpoint(GO:0031570) |
| 0.2 | 4.3 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.2 | 0.9 | GO:0036414 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
| 0.2 | 2.4 | GO:1904152 | regulation of retrograde protein transport, ER to cytosol(GO:1904152) |
| 0.2 | 1.5 | GO:0016266 | O-glycan processing(GO:0016266) |
| 0.2 | 7.2 | GO:0006334 | nucleosome assembly(GO:0006334) |
| 0.2 | 0.4 | GO:1903298 | regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903297) negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903298) |
| 0.2 | 11.3 | GO:0048661 | positive regulation of smooth muscle cell proliferation(GO:0048661) |
| 0.2 | 0.9 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
| 0.2 | 0.6 | GO:0002940 | tRNA N2-guanine methylation(GO:0002940) |
| 0.2 | 0.9 | GO:0048254 | snoRNA localization(GO:0048254) |
| 0.2 | 1.3 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
| 0.2 | 0.6 | GO:0018103 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
| 0.2 | 1.9 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
| 0.2 | 0.6 | GO:0071579 | regulation of zinc ion transport(GO:0071579) |
| 0.2 | 0.6 | GO:0016576 | histone dephosphorylation(GO:0016576) |
| 0.2 | 0.8 | GO:1902269 | positive regulation of polyamine transmembrane transport(GO:1902269) |
| 0.2 | 2.7 | GO:0070203 | regulation of establishment of protein localization to chromosome(GO:0070202) regulation of establishment of protein localization to telomere(GO:0070203) regulation of protein localization to chromosome, telomeric region(GO:1904814) positive regulation of protein localization to chromosome, telomeric region(GO:1904816) positive regulation of establishment of protein localization to telomere(GO:1904851) |
| 0.2 | 1.0 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
| 0.2 | 0.6 | GO:0090481 | pyrimidine nucleotide-sugar transmembrane transport(GO:0090481) |
| 0.2 | 0.4 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
| 0.2 | 1.4 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
| 0.2 | 1.6 | GO:0098728 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
| 0.2 | 0.6 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) dedifferentiation(GO:0043696) cell dedifferentiation(GO:0043697) |
| 0.2 | 5.0 | GO:0006261 | DNA-dependent DNA replication(GO:0006261) |
| 0.2 | 1.8 | GO:0086028 | bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
| 0.2 | 27.4 | GO:0007286 | spermatid development(GO:0007286) |
| 0.2 | 6.9 | GO:0006378 | mRNA polyadenylation(GO:0006378) RNA polyadenylation(GO:0043631) |
| 0.2 | 2.9 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
| 0.2 | 2.3 | GO:0048515 | spermatid differentiation(GO:0048515) |
| 0.2 | 2.8 | GO:0090527 | actin filament reorganization(GO:0090527) |
| 0.2 | 1.3 | GO:0048496 | maintenance of organ identity(GO:0048496) |
| 0.2 | 1.1 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
| 0.2 | 0.4 | GO:0015783 | GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
| 0.2 | 0.9 | GO:0032472 | Golgi calcium ion transport(GO:0032472) |
| 0.2 | 0.5 | GO:0046710 | GDP metabolic process(GO:0046710) |
| 0.2 | 20.0 | GO:0007050 | cell cycle arrest(GO:0007050) |
| 0.2 | 35.2 | GO:0051321 | meiotic cell cycle(GO:0051321) |
| 0.2 | 9.4 | GO:0009409 | response to cold(GO:0009409) |
| 0.2 | 4.1 | GO:2000401 | regulation of lymphocyte migration(GO:2000401) |
| 0.2 | 0.4 | GO:1903003 | positive regulation of protein deubiquitination(GO:1903003) |
| 0.2 | 2.8 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
| 0.2 | 1.2 | GO:0035067 | negative regulation of histone acetylation(GO:0035067) |
| 0.2 | 1.9 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
| 0.2 | 5.2 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
| 0.2 | 0.3 | GO:0045659 | regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
| 0.2 | 2.2 | GO:0071361 | cellular response to ethanol(GO:0071361) |
| 0.2 | 1.0 | GO:0060332 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
| 0.2 | 1.7 | GO:0060965 | negative regulation of gene silencing by miRNA(GO:0060965) |
| 0.2 | 2.2 | GO:0016139 | glycoside catabolic process(GO:0016139) |
| 0.2 | 1.3 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
| 0.2 | 0.8 | GO:0040016 | embryonic cleavage(GO:0040016) |
| 0.2 | 0.7 | GO:0042983 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
| 0.2 | 0.7 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
| 0.2 | 0.5 | GO:0035874 | amiloride transport(GO:0015898) cellular response to copper ion starvation(GO:0035874) response to azide(GO:0097184) cellular response to azide(GO:0097185) |
| 0.2 | 1.8 | GO:0051451 | myoblast migration(GO:0051451) |
| 0.2 | 2.3 | GO:1901798 | positive regulation of signal transduction by p53 class mediator(GO:1901798) |
| 0.2 | 8.3 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
| 0.2 | 2.6 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
| 0.2 | 1.0 | GO:0051013 | microtubule severing(GO:0051013) |
| 0.2 | 0.8 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
| 0.2 | 4.2 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
| 0.2 | 1.6 | GO:0036295 | cellular response to increased oxygen levels(GO:0036295) |
| 0.2 | 1.6 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
| 0.2 | 0.8 | GO:1902669 | positive regulation of axon guidance(GO:1902669) |
| 0.2 | 2.0 | GO:0010528 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
| 0.2 | 0.6 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
| 0.2 | 2.8 | GO:0010818 | T cell chemotaxis(GO:0010818) |
| 0.2 | 7.7 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
| 0.2 | 2.3 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
| 0.2 | 3.1 | GO:0051639 | actin filament network formation(GO:0051639) |
| 0.2 | 2.3 | GO:0003351 | epithelial cilium movement(GO:0003351) |
| 0.2 | 8.1 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
| 0.2 | 0.6 | GO:0072173 | metanephric tubule morphogenesis(GO:0072173) |
| 0.2 | 2.6 | GO:0051601 | exocyst localization(GO:0051601) |
| 0.2 | 5.9 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
| 0.1 | 0.6 | GO:0090327 | negative regulation of locomotion involved in locomotory behavior(GO:0090327) |
| 0.1 | 6.3 | GO:0009620 | response to fungus(GO:0009620) |
| 0.1 | 1.0 | GO:0019240 | citrulline biosynthetic process(GO:0019240) |
| 0.1 | 0.7 | GO:0060972 | left/right pattern formation(GO:0060972) |
| 0.1 | 0.9 | GO:0051409 | response to nitrosative stress(GO:0051409) |
| 0.1 | 0.8 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
| 0.1 | 0.4 | GO:1902267 | polyamine transport(GO:0015846) polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) |
| 0.1 | 0.6 | GO:0006669 | sphinganine-1-phosphate biosynthetic process(GO:0006669) |
| 0.1 | 3.6 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
| 0.1 | 3.6 | GO:0046653 | tetrahydrofolate metabolic process(GO:0046653) |
| 0.1 | 2.3 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
| 0.1 | 1.5 | GO:1903543 | regulation of exosomal secretion(GO:1903541) positive regulation of exosomal secretion(GO:1903543) |
| 0.1 | 0.5 | GO:0046351 | disaccharide biosynthetic process(GO:0046351) |
| 0.1 | 0.8 | GO:0035372 | protein localization to microtubule(GO:0035372) |
| 0.1 | 54.9 | GO:0051301 | cell division(GO:0051301) |
| 0.1 | 0.5 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
| 0.1 | 7.8 | GO:0046580 | negative regulation of Ras protein signal transduction(GO:0046580) negative regulation of small GTPase mediated signal transduction(GO:0051058) |
| 0.1 | 4.8 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
| 0.1 | 1.0 | GO:2000969 | positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
| 0.1 | 4.5 | GO:0030317 | sperm motility(GO:0030317) |
| 0.1 | 2.4 | GO:0006465 | signal peptide processing(GO:0006465) |
| 0.1 | 0.4 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
| 0.1 | 0.4 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
| 0.1 | 1.8 | GO:0002052 | positive regulation of neuroblast proliferation(GO:0002052) |
| 0.1 | 0.7 | GO:0032827 | negative regulation of natural killer cell differentiation(GO:0032824) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
| 0.1 | 1.8 | GO:0044458 | motile cilium assembly(GO:0044458) |
| 0.1 | 1.8 | GO:0097237 | cellular response to toxic substance(GO:0097237) |
| 0.1 | 1.2 | GO:0010561 | negative regulation of glycoprotein biosynthetic process(GO:0010561) |
| 0.1 | 2.8 | GO:0006817 | phosphate ion transport(GO:0006817) |
| 0.1 | 4.4 | GO:0042073 | intraciliary transport(GO:0042073) |
| 0.1 | 1.6 | GO:0006517 | protein deglycosylation(GO:0006517) |
| 0.1 | 0.5 | GO:0046381 | CMP-N-acetylneuraminate metabolic process(GO:0046381) |
| 0.1 | 0.2 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
| 0.1 | 0.6 | GO:0006379 | mRNA cleavage(GO:0006379) |
| 0.1 | 0.5 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
| 0.1 | 0.5 | GO:1902548 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) negative regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902548) |
| 0.1 | 34.3 | GO:0007283 | spermatogenesis(GO:0007283) male gamete generation(GO:0048232) |
| 0.1 | 1.2 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
| 0.1 | 0.3 | GO:1904158 | axonemal central apparatus assembly(GO:1904158) |
| 0.1 | 0.8 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
| 0.1 | 0.1 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
| 0.1 | 0.1 | GO:0042668 | auditory receptor cell fate determination(GO:0042668) |
| 0.1 | 1.4 | GO:1903427 | negative regulation of reactive oxygen species biosynthetic process(GO:1903427) |
| 0.1 | 0.3 | GO:0061090 | positive regulation of sequestering of zinc ion(GO:0061090) |
| 0.1 | 0.4 | GO:0090343 | positive regulation of cell aging(GO:0090343) positive regulation of cellular senescence(GO:2000774) |
| 0.1 | 1.2 | GO:0034626 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.1 | 0.8 | GO:0033227 | dsRNA transport(GO:0033227) |
| 0.1 | 0.6 | GO:0071918 | urea transmembrane transport(GO:0071918) |
| 0.1 | 12.5 | GO:0006281 | DNA repair(GO:0006281) |
| 0.1 | 0.3 | GO:0070846 | misfolded protein transport(GO:0070843) polyubiquitinated protein transport(GO:0070844) polyubiquitinated misfolded protein transport(GO:0070845) Hsp90 deacetylation(GO:0070846) regulation of chaperone-mediated protein complex assembly(GO:0090034) positive regulation of chaperone-mediated protein complex assembly(GO:0090035) |
| 0.1 | 3.3 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
| 0.1 | 0.7 | GO:1902564 | negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) negative regulation of neutrophil activation(GO:1902564) |
| 0.1 | 1.4 | GO:0000737 | DNA catabolic process, endonucleolytic(GO:0000737) apoptotic DNA fragmentation(GO:0006309) |
| 0.1 | 0.5 | GO:0071492 | cellular response to UV-A(GO:0071492) |
| 0.1 | 27.6 | GO:0006397 | mRNA processing(GO:0006397) |
| 0.1 | 0.9 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
| 0.1 | 7.5 | GO:0018107 | peptidyl-threonine phosphorylation(GO:0018107) |
| 0.1 | 0.2 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
| 0.1 | 6.8 | GO:0071356 | cellular response to tumor necrosis factor(GO:0071356) |
| 0.1 | 1.5 | GO:0072673 | lamellipodium morphogenesis(GO:0072673) |
| 0.1 | 0.6 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
| 0.1 | 0.3 | GO:1903756 | regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
| 0.1 | 0.9 | GO:0022615 | protein to membrane docking(GO:0022615) |
| 0.1 | 0.4 | GO:0071286 | cellular response to magnesium ion(GO:0071286) |
| 0.1 | 0.2 | GO:0021823 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) postnatal olfactory bulb interneuron migration(GO:0021827) |
| 0.1 | 0.7 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
| 0.1 | 2.1 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
| 0.1 | 0.8 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
| 0.1 | 0.3 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
| 0.1 | 0.8 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
| 0.1 | 0.9 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
| 0.1 | 3.2 | GO:0007520 | myoblast fusion(GO:0007520) |
| 0.1 | 0.4 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
| 0.1 | 0.9 | GO:0007379 | segment specification(GO:0007379) |
| 0.1 | 0.3 | GO:0016240 | autophagosome docking(GO:0016240) |
| 0.1 | 0.5 | GO:0060536 | cartilage morphogenesis(GO:0060536) |
| 0.1 | 0.5 | GO:0051697 | protein delipidation(GO:0051697) |
| 0.1 | 2.6 | GO:0001578 | microtubule bundle formation(GO:0001578) |
| 0.1 | 0.7 | GO:0002230 | positive regulation of defense response to virus by host(GO:0002230) |
| 0.1 | 6.4 | GO:0030177 | positive regulation of Wnt signaling pathway(GO:0030177) |
| 0.1 | 0.7 | GO:0031639 | plasminogen activation(GO:0031639) |
| 0.1 | 10.9 | GO:0060271 | cilium morphogenesis(GO:0060271) |
| 0.1 | 1.7 | GO:0010833 | telomere maintenance via telomere lengthening(GO:0010833) |
| 0.1 | 1.4 | GO:1901186 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) positive regulation of ERBB signaling pathway(GO:1901186) |
| 0.1 | 0.2 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
| 0.1 | 1.1 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
| 0.1 | 0.6 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
| 0.1 | 0.7 | GO:1903077 | negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
| 0.1 | 2.1 | GO:0007602 | phototransduction(GO:0007602) |
| 0.1 | 0.5 | GO:0098792 | xenophagy(GO:0098792) |
| 0.1 | 0.4 | GO:0072033 | renal vesicle formation(GO:0072033) |
| 0.1 | 0.6 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
| 0.1 | 0.9 | GO:0060290 | transdifferentiation(GO:0060290) |
| 0.1 | 0.4 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
| 0.1 | 0.9 | GO:0051225 | spindle assembly(GO:0051225) |
| 0.1 | 0.1 | GO:2000121 | regulation of removal of superoxide radicals(GO:2000121) |
| 0.1 | 1.0 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
| 0.1 | 0.8 | GO:0046686 | response to cadmium ion(GO:0046686) |
| 0.1 | 0.6 | GO:0010453 | regulation of cell fate commitment(GO:0010453) |
| 0.1 | 0.8 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
| 0.1 | 0.2 | GO:0060155 | platelet dense granule organization(GO:0060155) |
| 0.1 | 0.5 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
| 0.1 | 4.5 | GO:0007030 | Golgi organization(GO:0007030) |
| 0.1 | 0.3 | GO:0036490 | regulation of translation in response to endoplasmic reticulum stress(GO:0036490) regulation of translation initiation in response to endoplasmic reticulum stress(GO:0036491) eiF2alpha phosphorylation in response to endoplasmic reticulum stress(GO:0036492) |
| 0.1 | 0.2 | GO:2000983 | regulation of ATP citrate synthase activity(GO:2000983) negative regulation of ATP citrate synthase activity(GO:2000984) |
| 0.1 | 0.3 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
| 0.0 | 1.2 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
| 0.0 | 0.6 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
| 0.0 | 2.2 | GO:0051865 | protein autoubiquitination(GO:0051865) |
| 0.0 | 0.2 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
| 0.0 | 0.1 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
| 0.0 | 1.3 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
| 0.0 | 0.1 | GO:0007198 | adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) |
| 0.0 | 0.4 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
| 0.0 | 0.4 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
| 0.0 | 0.2 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
| 0.0 | 0.5 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
| 0.0 | 0.5 | GO:0042481 | regulation of odontogenesis(GO:0042481) |
| 0.0 | 1.2 | GO:0035634 | response to stilbenoid(GO:0035634) |
| 0.0 | 0.3 | GO:0009249 | protein lipoylation(GO:0009249) |
| 0.0 | 0.3 | GO:0021511 | spinal cord patterning(GO:0021511) |
| 0.0 | 8.6 | GO:0042113 | B cell activation(GO:0042113) |
| 0.0 | 0.2 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) |
| 0.0 | 0.3 | GO:0032959 | inositol trisphosphate biosynthetic process(GO:0032959) |
| 0.0 | 0.4 | GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
| 0.0 | 1.3 | GO:0006414 | translational elongation(GO:0006414) |
| 0.0 | 0.5 | GO:0030049 | muscle filament sliding(GO:0030049) |
| 0.0 | 0.1 | GO:0010626 | regulation of Schwann cell proliferation(GO:0010624) negative regulation of Schwann cell proliferation(GO:0010626) |
| 0.0 | 2.3 | GO:0007589 | body fluid secretion(GO:0007589) |
| 0.0 | 0.1 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
| 0.0 | 0.2 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
| 0.0 | 0.3 | GO:0009209 | pyrimidine ribonucleoside triphosphate metabolic process(GO:0009208) pyrimidine ribonucleoside triphosphate biosynthetic process(GO:0009209) |
| 0.0 | 0.2 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
| 0.0 | 1.9 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
| 0.0 | 0.4 | GO:0009437 | carnitine metabolic process(GO:0009437) |
| 0.0 | 0.3 | GO:0035646 | endosome to melanosome transport(GO:0035646) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
| 0.0 | 0.3 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
| 0.0 | 0.2 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
| 0.0 | 0.1 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
| 0.0 | 0.2 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) negative regulation of biomineral tissue development(GO:0070168) |
| 0.0 | 0.2 | GO:0048023 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
| 0.0 | 0.3 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
| 0.0 | 0.3 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
| 0.0 | 0.2 | GO:2001198 | regulation of dendritic cell differentiation(GO:2001198) negative regulation of dendritic cell differentiation(GO:2001199) |
| 0.0 | 0.2 | GO:0015727 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
| 0.0 | 0.5 | GO:0051290 | protein heterotetramerization(GO:0051290) |
| 0.0 | 0.2 | GO:0043248 | proteasome assembly(GO:0043248) |
| 0.0 | 0.2 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
| 0.0 | 0.1 | GO:0048570 | notochord morphogenesis(GO:0048570) |
| 0.0 | 0.0 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
| 0.0 | 0.1 | GO:0016553 | base conversion or substitution editing(GO:0016553) |
| 0.0 | 0.1 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
| 0.0 | 2.6 | GO:0002377 | immunoglobulin production(GO:0002377) |
| 0.0 | 0.2 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
| 0.0 | 0.1 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
| 0.0 | 0.6 | GO:0010507 | negative regulation of autophagy(GO:0010507) |
| 0.0 | 0.0 | GO:0046794 | multi-organism transport(GO:0044766) transport of virus(GO:0046794) intracellular transport of virus(GO:0075733) regulation of intracellular transport of viral material(GO:1901252) multi-organism localization(GO:1902579) multi-organism intracellular transport(GO:1902583) |
| 0.0 | 0.0 | GO:0071895 | odontoblast differentiation(GO:0071895) |
| 0.0 | 0.2 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
| 0.0 | 0.1 | GO:0002115 | store-operated calcium entry(GO:0002115) |
Gene overrepresentation in cellular component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 16.7 | 100.4 | GO:0097149 | centralspindlin complex(GO:0097149) |
| 10.1 | 40.3 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
| 8.6 | 42.9 | GO:0000799 | nuclear condensin complex(GO:0000799) |
| 8.4 | 50.2 | GO:0032133 | chromosome passenger complex(GO:0032133) |
| 7.5 | 22.5 | GO:0097135 | cyclin E2-CDK2 complex(GO:0097135) |
| 7.0 | 21.0 | GO:0036387 | nuclear pre-replicative complex(GO:0005656) pre-replicative complex(GO:0036387) |
| 5.5 | 22.0 | GO:1990298 | mitotic checkpoint complex(GO:0033597) bub1-bub3 complex(GO:1990298) |
| 5.0 | 25.2 | GO:0031262 | Ndc80 complex(GO:0031262) |
| 4.1 | 12.3 | GO:0002945 | cyclin K-CDK12 complex(GO:0002944) cyclin K-CDK13 complex(GO:0002945) |
| 3.9 | 19.3 | GO:0035189 | Rb-E2F complex(GO:0035189) |
| 3.8 | 37.8 | GO:0072687 | meiotic spindle(GO:0072687) |
| 3.6 | 39.2 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
| 3.4 | 20.6 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
| 3.3 | 9.8 | GO:0032783 | ELL-EAF complex(GO:0032783) |
| 3.2 | 38.9 | GO:0042613 | MHC class II protein complex(GO:0042613) |
| 3.2 | 41.1 | GO:0005818 | aster(GO:0005818) |
| 3.1 | 24.7 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
| 3.1 | 12.3 | GO:0000939 | condensed chromosome inner kinetochore(GO:0000939) |
| 2.9 | 8.8 | GO:1990031 | pinceau fiber(GO:1990031) |
| 2.9 | 17.2 | GO:0071547 | piP-body(GO:0071547) |
| 2.7 | 43.4 | GO:0042555 | MCM complex(GO:0042555) |
| 2.6 | 26.3 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
| 2.5 | 15.2 | GO:0008278 | cohesin complex(GO:0008278) |
| 2.5 | 14.9 | GO:1990356 | sumoylated E2 ligase complex(GO:1990356) |
| 2.4 | 34.3 | GO:0042612 | MHC class I protein complex(GO:0042612) |
| 2.4 | 19.2 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
| 2.3 | 11.7 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
| 2.2 | 6.7 | GO:0031298 | replication fork protection complex(GO:0031298) |
| 2.1 | 61.9 | GO:0010369 | chromocenter(GO:0010369) |
| 2.0 | 6.1 | GO:0097123 | cyclin A1-CDK2 complex(GO:0097123) |
| 2.0 | 6.0 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
| 2.0 | 2.0 | GO:0042585 | germinal vesicle(GO:0042585) |
| 1.9 | 18.9 | GO:0042382 | paraspeckles(GO:0042382) |
| 1.8 | 5.3 | GO:1990423 | RZZ complex(GO:1990423) |
| 1.6 | 6.5 | GO:0033186 | CAF-1 complex(GO:0033186) |
| 1.6 | 14.4 | GO:0045298 | tubulin complex(GO:0045298) |
| 1.6 | 4.8 | GO:0005760 | gamma DNA polymerase complex(GO:0005760) |
| 1.6 | 17.6 | GO:0005677 | chromatin silencing complex(GO:0005677) |
| 1.6 | 80.9 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
| 1.6 | 31.4 | GO:0031616 | spindle pole centrosome(GO:0031616) |
| 1.6 | 20.3 | GO:0000788 | nuclear nucleosome(GO:0000788) |
| 1.5 | 7.5 | GO:0034657 | GID complex(GO:0034657) |
| 1.5 | 4.5 | GO:0031261 | DNA replication preinitiation complex(GO:0031261) |
| 1.5 | 4.5 | GO:0005712 | chiasma(GO:0005712) late recombination nodule(GO:0005715) |
| 1.5 | 10.3 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
| 1.4 | 7.2 | GO:0031251 | PAN complex(GO:0031251) |
| 1.4 | 8.5 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
| 1.4 | 1.4 | GO:0071821 | FANCM-MHF complex(GO:0071821) |
| 1.4 | 8.2 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
| 1.3 | 5.2 | GO:0002111 | BRCA2-BRAF35 complex(GO:0002111) |
| 1.3 | 7.7 | GO:0005828 | kinetochore microtubule(GO:0005828) |
| 1.3 | 170.7 | GO:0005814 | centriole(GO:0005814) |
| 1.3 | 32.6 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
| 1.2 | 39.0 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
| 1.2 | 6.0 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
| 1.2 | 86.8 | GO:0005657 | replication fork(GO:0005657) |
| 1.2 | 17.7 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
| 1.2 | 149.5 | GO:0000776 | kinetochore(GO:0000776) |
| 1.1 | 20.3 | GO:0000242 | pericentriolar material(GO:0000242) |
| 1.1 | 6.7 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
| 1.1 | 6.6 | GO:0032300 | mismatch repair complex(GO:0032300) |
| 1.1 | 23.9 | GO:0031011 | Ino80 complex(GO:0031011) |
| 1.1 | 7.5 | GO:0070187 | telosome(GO:0070187) |
| 1.1 | 27.8 | GO:0045120 | pronucleus(GO:0045120) |
| 1.1 | 4.2 | GO:0000438 | core TFIIH complex portion of holo TFIIH complex(GO:0000438) |
| 1.1 | 3.2 | GO:0030870 | Mre11 complex(GO:0030870) |
| 1.0 | 9.4 | GO:0031211 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
| 1.0 | 30.7 | GO:0005876 | spindle microtubule(GO:0005876) |
| 1.0 | 5.0 | GO:0071144 | activin responsive factor complex(GO:0032444) SMAD2-SMAD3 protein complex(GO:0071144) |
| 1.0 | 5.0 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
| 1.0 | 3.9 | GO:0032127 | dense core granule membrane(GO:0032127) |
| 1.0 | 6.9 | GO:0036396 | MIS complex(GO:0036396) |
| 0.9 | 0.9 | GO:0035061 | interchromatin granule(GO:0035061) |
| 0.9 | 7.3 | GO:0042825 | TAP complex(GO:0042825) |
| 0.9 | 55.9 | GO:0005871 | kinesin complex(GO:0005871) |
| 0.9 | 4.5 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
| 0.9 | 22.3 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
| 0.9 | 11.5 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
| 0.9 | 2.6 | GO:0000109 | nucleotide-excision repair complex(GO:0000109) |
| 0.9 | 2.6 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
| 0.9 | 9.4 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) RISC-loading complex(GO:0070578) |
| 0.9 | 12.8 | GO:0097431 | mitotic spindle pole(GO:0097431) |
| 0.8 | 9.8 | GO:0034709 | methylosome(GO:0034709) |
| 0.8 | 1.6 | GO:0000974 | Prp19 complex(GO:0000974) |
| 0.8 | 2.4 | GO:0005673 | transcription factor TFIIE complex(GO:0005673) |
| 0.8 | 16.9 | GO:0005682 | U5 snRNP(GO:0005682) |
| 0.8 | 4.0 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
| 0.8 | 15.8 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
| 0.8 | 23.2 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
| 0.8 | 3.1 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
| 0.7 | 2.2 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
| 0.7 | 5.1 | GO:0099524 | region of cytosol(GO:0099522) postsynaptic cytosol(GO:0099524) |
| 0.7 | 8.3 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
| 0.7 | 21.5 | GO:0001891 | phagocytic cup(GO:0001891) |
| 0.7 | 15.4 | GO:0035861 | site of double-strand break(GO:0035861) |
| 0.7 | 4.6 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
| 0.7 | 3.3 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
| 0.7 | 5.2 | GO:0042405 | nuclear inclusion body(GO:0042405) |
| 0.7 | 5.2 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
| 0.6 | 147.7 | GO:0000793 | condensed chromosome(GO:0000793) |
| 0.6 | 1.3 | GO:0043186 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
| 0.6 | 7.6 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
| 0.6 | 51.5 | GO:0005643 | nuclear pore(GO:0005643) |
| 0.6 | 15.4 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
| 0.6 | 7.3 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
| 0.6 | 2.4 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
| 0.6 | 7.3 | GO:0016589 | NURF complex(GO:0016589) |
| 0.6 | 0.6 | GO:0005687 | U4 snRNP(GO:0005687) |
| 0.6 | 8.9 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
| 0.6 | 3.5 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
| 0.6 | 3.5 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
| 0.6 | 2.9 | GO:0034464 | BBSome(GO:0034464) |
| 0.6 | 2.8 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
| 0.6 | 0.6 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
| 0.5 | 4.4 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
| 0.5 | 4.4 | GO:0097542 | ciliary tip(GO:0097542) |
| 0.5 | 7.5 | GO:0030061 | mitochondrial crista(GO:0030061) |
| 0.5 | 5.8 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
| 0.5 | 19.7 | GO:0045171 | intercellular bridge(GO:0045171) |
| 0.5 | 11.1 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
| 0.5 | 7.6 | GO:0031209 | SCAR complex(GO:0031209) |
| 0.5 | 3.9 | GO:0060091 | kinocilium(GO:0060091) |
| 0.5 | 2.9 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
| 0.5 | 7.5 | GO:0033391 | chromatoid body(GO:0033391) |
| 0.5 | 2.8 | GO:0070695 | FHF complex(GO:0070695) |
| 0.5 | 47.2 | GO:0016605 | PML body(GO:0016605) |
| 0.5 | 4.5 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
| 0.4 | 3.6 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
| 0.4 | 4.4 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
| 0.4 | 1.3 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
| 0.4 | 5.2 | GO:0048500 | signal recognition particle(GO:0048500) |
| 0.4 | 305.0 | GO:0005694 | chromosome(GO:0005694) |
| 0.4 | 6.4 | GO:0000346 | transcription export complex(GO:0000346) |
| 0.4 | 2.1 | GO:0097452 | GAIT complex(GO:0097452) |
| 0.4 | 29.0 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
| 0.4 | 2.0 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
| 0.4 | 0.8 | GO:0034457 | Mpp10 complex(GO:0034457) |
| 0.4 | 3.2 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
| 0.4 | 6.2 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
| 0.4 | 10.8 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
| 0.4 | 1.1 | GO:0017109 | glutamate-cysteine ligase complex(GO:0017109) |
| 0.4 | 24.3 | GO:0016363 | nuclear matrix(GO:0016363) |
| 0.4 | 1.1 | GO:0071141 | SMAD protein complex(GO:0071141) |
| 0.4 | 33.6 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
| 0.4 | 1.1 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
| 0.4 | 1.5 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
| 0.4 | 6.4 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
| 0.4 | 4.6 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
| 0.4 | 3.2 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
| 0.3 | 2.4 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
| 0.3 | 36.5 | GO:0005795 | Golgi stack(GO:0005795) |
| 0.3 | 3.2 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
| 0.3 | 52.5 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
| 0.3 | 0.9 | GO:0097361 | CIA complex(GO:0097361) |
| 0.3 | 3.7 | GO:0036128 | CatSper complex(GO:0036128) |
| 0.3 | 1.2 | GO:0097447 | dendritic tree(GO:0097447) |
| 0.3 | 9.1 | GO:0002080 | acrosomal membrane(GO:0002080) |
| 0.3 | 1.5 | GO:1990923 | PET complex(GO:1990923) |
| 0.3 | 2.7 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
| 0.3 | 10.5 | GO:0031519 | PcG protein complex(GO:0031519) |
| 0.3 | 6.1 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
| 0.3 | 119.3 | GO:0005813 | centrosome(GO:0005813) |
| 0.3 | 6.6 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
| 0.3 | 1.9 | GO:0097443 | sorting endosome(GO:0097443) |
| 0.3 | 7.0 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
| 0.3 | 3.0 | GO:0070938 | contractile ring(GO:0070938) |
| 0.3 | 3.7 | GO:0032039 | integrator complex(GO:0032039) |
| 0.3 | 2.6 | GO:0005787 | signal peptidase complex(GO:0005787) |
| 0.3 | 13.2 | GO:0036064 | ciliary basal body(GO:0036064) |
| 0.3 | 1.5 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
| 0.3 | 1.5 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
| 0.2 | 1.5 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
| 0.2 | 0.7 | GO:0043291 | RAVE complex(GO:0043291) |
| 0.2 | 1.4 | GO:0070820 | tertiary granule(GO:0070820) |
| 0.2 | 22.2 | GO:0036126 | sperm flagellum(GO:0036126) |
| 0.2 | 1.2 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
| 0.2 | 0.6 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
| 0.2 | 2.5 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
| 0.2 | 0.4 | GO:0043159 | acrosomal matrix(GO:0043159) |
| 0.2 | 3.8 | GO:0070461 | SAGA-type complex(GO:0070461) |
| 0.2 | 4.7 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
| 0.2 | 51.5 | GO:0016607 | nuclear speck(GO:0016607) |
| 0.2 | 1.0 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
| 0.2 | 8.4 | GO:0031201 | SNARE complex(GO:0031201) |
| 0.2 | 3.0 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
| 0.2 | 7.2 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
| 0.1 | 8.9 | GO:0005681 | spliceosomal complex(GO:0005681) |
| 0.1 | 5.3 | GO:0016592 | mediator complex(GO:0016592) |
| 0.1 | 3.5 | GO:0015030 | Cajal body(GO:0015030) |
| 0.1 | 1.6 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
| 0.1 | 9.0 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
| 0.1 | 0.8 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
| 0.1 | 9.2 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
| 0.1 | 25.9 | GO:0031965 | nuclear membrane(GO:0031965) |
| 0.1 | 0.3 | GO:1990716 | axonemal central apparatus(GO:1990716) |
| 0.1 | 3.4 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
| 0.1 | 14.0 | GO:0001650 | fibrillar center(GO:0001650) |
| 0.1 | 0.9 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
| 0.1 | 7.4 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
| 0.1 | 1.2 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
| 0.1 | 0.4 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
| 0.1 | 1.7 | GO:0030008 | TRAPP complex(GO:0030008) |
| 0.1 | 5.3 | GO:0005815 | microtubule organizing center(GO:0005815) |
| 0.1 | 0.5 | GO:0016461 | unconventional myosin complex(GO:0016461) |
| 0.1 | 0.2 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
| 0.1 | 2.6 | GO:0030686 | 90S preribosome(GO:0030686) |
| 0.1 | 0.9 | GO:0036156 | inner dynein arm(GO:0036156) |
| 0.1 | 0.8 | GO:0000813 | ESCRT I complex(GO:0000813) |
| 0.1 | 4.0 | GO:0031941 | filamentous actin(GO:0031941) |
| 0.1 | 0.2 | GO:0043219 | lateral loop(GO:0043219) |
| 0.1 | 5.4 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
| 0.1 | 0.6 | GO:0042629 | mast cell granule(GO:0042629) |
| 0.1 | 0.6 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
| 0.1 | 0.6 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
| 0.1 | 0.8 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
| 0.1 | 14.8 | GO:0005667 | transcription factor complex(GO:0005667) |
| 0.1 | 1.5 | GO:0044452 | nucleolar part(GO:0044452) |
| 0.1 | 11.7 | GO:0016604 | nuclear body(GO:0016604) |
| 0.1 | 0.3 | GO:0017177 | glucosidase II complex(GO:0017177) |
| 0.1 | 0.2 | GO:0046691 | intracellular canaliculus(GO:0046691) |
| 0.1 | 1.7 | GO:0016235 | aggresome(GO:0016235) |
| 0.1 | 1.1 | GO:0097449 | astrocyte projection(GO:0097449) |
| 0.0 | 0.4 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
| 0.0 | 1.8 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
| 0.0 | 0.8 | GO:0045277 | respiratory chain complex IV(GO:0045277) |
| 0.0 | 0.0 | GO:0031010 | ISWI-type complex(GO:0031010) |
| 0.0 | 0.3 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
| 0.0 | 0.2 | GO:0016600 | flotillin complex(GO:0016600) |
| 0.0 | 1.6 | GO:0035770 | ribonucleoprotein granule(GO:0035770) |
| 0.0 | 0.2 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
| 0.0 | 0.4 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
| 0.0 | 0.3 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
| 0.0 | 0.2 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
| 0.0 | 1.3 | GO:0031514 | motile cilium(GO:0031514) |
| 0.0 | 1.2 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
| 0.0 | 0.1 | GO:0071953 | elastic fiber(GO:0071953) |
| 0.0 | 0.2 | GO:0032585 | multivesicular body membrane(GO:0032585) |
| 0.0 | 0.1 | GO:1990130 | Iml1 complex(GO:1990130) |
| 0.0 | 0.3 | GO:0042589 | zymogen granule membrane(GO:0042589) |
| 0.0 | 1.7 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
| 0.0 | 0.1 | GO:0008537 | proteasome activator complex(GO:0008537) |
Gene overrepresentation in molecular function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 13.9 | 55.7 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
| 10.5 | 10.5 | GO:0097472 | cyclin-dependent protein kinase activity(GO:0097472) |
| 9.3 | 55.8 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
| 7.2 | 72.3 | GO:0050786 | RAGE receptor binding(GO:0050786) |
| 6.3 | 50.7 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
| 4.6 | 27.7 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
| 4.0 | 15.9 | GO:0071207 | histone pre-mRNA stem-loop binding(GO:0071207) |
| 3.8 | 11.5 | GO:0033680 | ATP-dependent DNA/RNA helicase activity(GO:0033680) |
| 3.2 | 15.9 | GO:0042610 | CD8 receptor binding(GO:0042610) |
| 3.1 | 15.3 | GO:0000700 | mismatch base pair DNA N-glycosylase activity(GO:0000700) |
| 3.0 | 48.6 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
| 3.0 | 24.0 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
| 3.0 | 20.7 | GO:0043515 | kinetochore binding(GO:0043515) |
| 2.9 | 11.5 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
| 2.7 | 13.4 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
| 2.6 | 7.7 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
| 2.5 | 14.9 | GO:0061656 | SUMO conjugating enzyme activity(GO:0061656) |
| 2.4 | 7.2 | GO:0000402 | open form four-way junction DNA binding(GO:0000401) crossed form four-way junction DNA binding(GO:0000402) |
| 2.4 | 7.1 | GO:0030226 | apolipoprotein receptor activity(GO:0030226) apolipoprotein A-I receptor activity(GO:0034188) phosphatidylserine-translocating ATPase activity(GO:0090556) |
| 2.2 | 6.7 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
| 2.2 | 11.0 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
| 2.2 | 4.4 | GO:0032357 | oxidized purine DNA binding(GO:0032357) |
| 2.1 | 37.0 | GO:0046977 | TAP binding(GO:0046977) |
| 2.0 | 7.9 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
| 1.9 | 17.0 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
| 1.8 | 58.4 | GO:0035173 | histone kinase activity(GO:0035173) |
| 1.8 | 12.6 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
| 1.7 | 40.9 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
| 1.7 | 5.0 | GO:0008967 | phosphoglycolate phosphatase activity(GO:0008967) |
| 1.7 | 26.8 | GO:0003688 | DNA replication origin binding(GO:0003688) |
| 1.7 | 5.0 | GO:0098918 | structural constituent of synapse(GO:0098918) structural constituent of postsynaptic actin cytoskeleton(GO:0098973) |
| 1.7 | 9.9 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
| 1.6 | 21.3 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
| 1.6 | 6.5 | GO:0003998 | acylphosphatase activity(GO:0003998) |
| 1.6 | 6.3 | GO:0030519 | snoRNP binding(GO:0030519) |
| 1.6 | 9.4 | GO:0070883 | pre-miRNA binding(GO:0070883) |
| 1.6 | 20.3 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
| 1.5 | 6.1 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
| 1.5 | 4.5 | GO:0004844 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
| 1.5 | 6.0 | GO:0031720 | haptoglobin binding(GO:0031720) |
| 1.5 | 10.4 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
| 1.5 | 10.3 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
| 1.5 | 53.8 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
| 1.4 | 54.8 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
| 1.4 | 53.9 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
| 1.4 | 4.2 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
| 1.4 | 9.6 | GO:0055104 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
| 1.4 | 4.1 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
| 1.4 | 30.2 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
| 1.3 | 6.4 | GO:0034584 | piRNA binding(GO:0034584) |
| 1.3 | 3.9 | GO:0001160 | transcription termination site sequence-specific DNA binding(GO:0001147) transcription termination site DNA binding(GO:0001160) |
| 1.3 | 10.0 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
| 1.2 | 8.6 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
| 1.2 | 3.6 | GO:0004420 | hydroxymethylglutaryl-CoA reductase (NADPH) activity(GO:0004420) hydroxymethylglutaryl-CoA reductase activity(GO:0042282) |
| 1.2 | 6.0 | GO:0016454 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
| 1.2 | 3.5 | GO:0009918 | sterol delta7 reductase activity(GO:0009918) 7-dehydrocholesterol reductase activity(GO:0047598) |
| 1.2 | 8.1 | GO:0015616 | DNA translocase activity(GO:0015616) |
| 1.1 | 8.0 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
| 1.1 | 12.5 | GO:0098505 | G-rich strand telomeric DNA binding(GO:0098505) |
| 1.1 | 3.4 | GO:0004326 | tetrahydrofolylpolyglutamate synthase activity(GO:0004326) |
| 1.1 | 3.4 | GO:0004512 | inositol-3-phosphate synthase activity(GO:0004512) intramolecular lyase activity(GO:0016872) |
| 1.1 | 4.5 | GO:0036313 | phosphatidylinositol 3-kinase catalytic subunit binding(GO:0036313) |
| 1.1 | 123.2 | GO:0003777 | microtubule motor activity(GO:0003777) |
| 1.0 | 12.5 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
| 1.0 | 5.0 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
| 1.0 | 5.9 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
| 1.0 | 5.9 | GO:0042289 | MHC class II protein binding(GO:0042289) |
| 1.0 | 7.8 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
| 1.0 | 2.9 | GO:0004082 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
| 1.0 | 22.0 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
| 0.9 | 2.8 | GO:0005174 | CD40 receptor binding(GO:0005174) |
| 0.9 | 2.8 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
| 0.9 | 4.6 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
| 0.9 | 4.4 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
| 0.9 | 6.2 | GO:0050733 | RS domain binding(GO:0050733) |
| 0.9 | 13.0 | GO:0030274 | LIM domain binding(GO:0030274) |
| 0.9 | 12.1 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
| 0.9 | 8.5 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
| 0.9 | 6.0 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
| 0.8 | 4.2 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
| 0.8 | 5.0 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
| 0.8 | 176.7 | GO:0042393 | histone binding(GO:0042393) |
| 0.8 | 8.2 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
| 0.8 | 6.5 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
| 0.8 | 7.3 | GO:0000150 | recombinase activity(GO:0000150) |
| 0.8 | 12.9 | GO:0031386 | protein tag(GO:0031386) |
| 0.8 | 2.4 | GO:0004418 | hydroxymethylbilane synthase activity(GO:0004418) |
| 0.8 | 3.2 | GO:0019809 | spermidine binding(GO:0019809) |
| 0.8 | 15.0 | GO:0042288 | MHC class I protein binding(GO:0042288) |
| 0.8 | 7.9 | GO:0051434 | BH3 domain binding(GO:0051434) |
| 0.8 | 3.9 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
| 0.8 | 1.5 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
| 0.8 | 3.8 | GO:0016435 | rRNA (guanine) methyltransferase activity(GO:0016435) |
| 0.8 | 4.5 | GO:0070728 | leucine binding(GO:0070728) |
| 0.8 | 3.0 | GO:0034437 | glycoprotein transporter activity(GO:0034437) |
| 0.7 | 2.9 | GO:0033883 | pyridoxal phosphatase activity(GO:0033883) |
| 0.7 | 5.0 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
| 0.7 | 7.1 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
| 0.7 | 2.1 | GO:0004572 | mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity(GO:0004572) |
| 0.7 | 6.2 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
| 0.7 | 5.5 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
| 0.7 | 4.8 | GO:0030614 | oxidoreductase activity, acting on phosphorus or arsenic in donors(GO:0030613) oxidoreductase activity, acting on phosphorus or arsenic in donors, disulfide as acceptor(GO:0030614) glutathione dehydrogenase (ascorbate) activity(GO:0045174) methylarsonate reductase activity(GO:0050610) |
| 0.7 | 4.1 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
| 0.7 | 28.7 | GO:0043175 | RNA polymerase core enzyme binding(GO:0043175) |
| 0.7 | 2.0 | GO:0004473 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) |
| 0.7 | 4.0 | GO:0015232 | heme transporter activity(GO:0015232) |
| 0.7 | 2.6 | GO:0048030 | disaccharide binding(GO:0048030) |
| 0.6 | 2.6 | GO:0045131 | pre-mRNA branch point binding(GO:0045131) |
| 0.6 | 33.8 | GO:0061650 | ubiquitin conjugating enzyme activity(GO:0061631) ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
| 0.6 | 3.9 | GO:1990715 | mRNA CDS binding(GO:1990715) |
| 0.6 | 12.9 | GO:0017091 | AU-rich element binding(GO:0017091) |
| 0.6 | 15.9 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
| 0.6 | 8.1 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
| 0.6 | 1.2 | GO:0019237 | centromeric DNA binding(GO:0019237) |
| 0.6 | 38.5 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
| 0.6 | 3.7 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
| 0.6 | 3.1 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
| 0.6 | 6.8 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
| 0.6 | 1.8 | GO:0003896 | DNA primase activity(GO:0003896) |
| 0.6 | 1.8 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
| 0.6 | 10.0 | GO:0031491 | nucleosome binding(GO:0031491) |
| 0.6 | 4.7 | GO:0034235 | GPI anchor binding(GO:0034235) |
| 0.6 | 6.3 | GO:1990405 | protein antigen binding(GO:1990405) |
| 0.6 | 2.8 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
| 0.6 | 3.4 | GO:0036310 | annealing helicase activity(GO:0036310) |
| 0.6 | 4.5 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
| 0.6 | 91.7 | GO:0017048 | Rho GTPase binding(GO:0017048) |
| 0.6 | 2.8 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
| 0.6 | 2.8 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
| 0.6 | 3.3 | GO:0008142 | oxysterol binding(GO:0008142) |
| 0.5 | 3.3 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
| 0.5 | 8.8 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
| 0.5 | 6.0 | GO:0033691 | sialic acid binding(GO:0033691) |
| 0.5 | 6.5 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
| 0.5 | 2.7 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
| 0.5 | 3.7 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
| 0.5 | 3.6 | GO:0061665 | SUMO ligase activity(GO:0061665) |
| 0.5 | 4.2 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
| 0.5 | 5.2 | GO:0050692 | DBD domain binding(GO:0050692) |
| 0.5 | 16.5 | GO:0070840 | dynein complex binding(GO:0070840) |
| 0.5 | 4.1 | GO:0070644 | vitamin D response element binding(GO:0070644) |
| 0.5 | 13.7 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
| 0.5 | 8.6 | GO:0043495 | protein anchor(GO:0043495) |
| 0.5 | 2.0 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
| 0.5 | 13.4 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
| 0.5 | 10.8 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
| 0.5 | 2.9 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
| 0.5 | 1.0 | GO:0032135 | DNA insertion or deletion binding(GO:0032135) |
| 0.5 | 5.3 | GO:0008494 | translation activator activity(GO:0008494) |
| 0.5 | 1.9 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
| 0.5 | 1.4 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
| 0.5 | 5.7 | GO:0009881 | photoreceptor activity(GO:0009881) |
| 0.5 | 7.6 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
| 0.5 | 1.9 | GO:0005136 | interleukin-4 receptor binding(GO:0005136) |
| 0.5 | 2.3 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
| 0.5 | 44.0 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
| 0.5 | 6.4 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
| 0.4 | 1.8 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
| 0.4 | 25.1 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
| 0.4 | 4.0 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
| 0.4 | 3.1 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
| 0.4 | 2.6 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
| 0.4 | 0.4 | GO:0004372 | glycine hydroxymethyltransferase activity(GO:0004372) |
| 0.4 | 3.0 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
| 0.4 | 2.6 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
| 0.4 | 5.9 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
| 0.4 | 4.6 | GO:0016004 | phospholipase activator activity(GO:0016004) |
| 0.4 | 33.1 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
| 0.4 | 1.2 | GO:0071820 | N-box binding(GO:0071820) |
| 0.4 | 2.5 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
| 0.4 | 2.4 | GO:0032184 | SUMO polymer binding(GO:0032184) |
| 0.4 | 1.2 | GO:0015928 | alpha-L-fucosidase activity(GO:0004560) fucosidase activity(GO:0015928) |
| 0.4 | 3.5 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
| 0.4 | 1.6 | GO:0045159 | myosin II binding(GO:0045159) |
| 0.4 | 13.6 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
| 0.4 | 2.3 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
| 0.4 | 1.9 | GO:0008301 | DNA binding, bending(GO:0008301) |
| 0.4 | 1.1 | GO:0004357 | glutamate-cysteine ligase activity(GO:0004357) |
| 0.4 | 3.8 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
| 0.4 | 2.3 | GO:0047844 | deoxycytidine deaminase activity(GO:0047844) |
| 0.4 | 1.5 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
| 0.4 | 2.2 | GO:0016433 | rRNA (adenine) methyltransferase activity(GO:0016433) |
| 0.4 | 21.7 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
| 0.4 | 7.5 | GO:0004697 | protein kinase C activity(GO:0004697) |
| 0.4 | 14.6 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
| 0.4 | 4.2 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
| 0.3 | 1.0 | GO:0032551 | UTP binding(GO:0002134) carbamoyl-phosphate synthase (ammonia) activity(GO:0004087) carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity(GO:0004088) pyrimidine ribonucleoside binding(GO:0032551) |
| 0.3 | 1.3 | GO:0004103 | choline kinase activity(GO:0004103) |
| 0.3 | 83.6 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
| 0.3 | 1.0 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
| 0.3 | 35.6 | GO:0004386 | helicase activity(GO:0004386) |
| 0.3 | 12.8 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
| 0.3 | 1.9 | GO:0004359 | glutaminase activity(GO:0004359) |
| 0.3 | 5.1 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
| 0.3 | 9.8 | GO:0017025 | TBP-class protein binding(GO:0017025) |
| 0.3 | 2.5 | GO:0042608 | T cell receptor binding(GO:0042608) |
| 0.3 | 0.9 | GO:0035870 | dITP diphosphatase activity(GO:0035870) |
| 0.3 | 1.8 | GO:1990254 | keratin filament binding(GO:1990254) |
| 0.3 | 0.9 | GO:0015140 | malate transmembrane transporter activity(GO:0015140) |
| 0.3 | 21.2 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
| 0.3 | 3.3 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
| 0.3 | 4.8 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
| 0.3 | 0.6 | GO:0030622 | U4atac snRNA binding(GO:0030622) |
| 0.3 | 0.6 | GO:0036033 | mediator complex binding(GO:0036033) |
| 0.3 | 1.2 | GO:0033142 | progesterone receptor binding(GO:0033142) |
| 0.3 | 2.0 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
| 0.3 | 1.4 | GO:1990188 | euchromatin binding(GO:1990188) |
| 0.3 | 0.8 | GO:0008502 | melatonin receptor activity(GO:0008502) |
| 0.3 | 1.1 | GO:1990460 | leptin receptor binding(GO:1990460) |
| 0.3 | 4.9 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
| 0.3 | 0.8 | GO:0005137 | interleukin-5 receptor binding(GO:0005137) |
| 0.3 | 3.2 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
| 0.3 | 3.4 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
| 0.3 | 3.1 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
| 0.3 | 0.8 | GO:0030345 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
| 0.3 | 15.3 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
| 0.2 | 1.7 | GO:0004969 | histamine receptor activity(GO:0004969) |
| 0.2 | 1.2 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
| 0.2 | 0.5 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
| 0.2 | 0.9 | GO:0008515 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
| 0.2 | 1.2 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
| 0.2 | 2.5 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
| 0.2 | 0.7 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
| 0.2 | 0.7 | GO:0008312 | 7S RNA binding(GO:0008312) |
| 0.2 | 4.8 | GO:0008536 | Ran GTPase binding(GO:0008536) |
| 0.2 | 0.7 | GO:0052692 | raffinose alpha-galactosidase activity(GO:0052692) |
| 0.2 | 0.9 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
| 0.2 | 10.4 | GO:0005484 | SNAP receptor activity(GO:0005484) |
| 0.2 | 3.8 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
| 0.2 | 2.7 | GO:0051861 | glycolipid binding(GO:0051861) |
| 0.2 | 6.0 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
| 0.2 | 0.8 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
| 0.2 | 0.6 | GO:0019959 | interleukin-8 binding(GO:0019959) |
| 0.2 | 3.0 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
| 0.2 | 5.0 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
| 0.2 | 5.9 | GO:0036002 | pre-mRNA binding(GO:0036002) |
| 0.2 | 1.0 | GO:0003880 | protein C-terminal carboxyl O-methyltransferase activity(GO:0003880) |
| 0.2 | 2.3 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
| 0.2 | 2.5 | GO:1990446 | snRNP binding(GO:0070990) U1 snRNP binding(GO:1990446) |
| 0.2 | 4.5 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
| 0.2 | 1.2 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
| 0.2 | 3.3 | GO:0043274 | phospholipase binding(GO:0043274) |
| 0.2 | 5.0 | GO:0003684 | damaged DNA binding(GO:0003684) |
| 0.2 | 2.5 | GO:0043422 | protein kinase B binding(GO:0043422) |
| 0.2 | 2.3 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
| 0.2 | 0.9 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
| 0.2 | 0.4 | GO:0001034 | RNA polymerase III transcription factor activity, sequence-specific DNA binding(GO:0001034) |
| 0.2 | 0.5 | GO:0004461 | lactose synthase activity(GO:0004461) |
| 0.2 | 39.3 | GO:0008017 | microtubule binding(GO:0008017) |
| 0.2 | 0.5 | GO:0044715 | 8-oxo-dGDP phosphatase activity(GO:0044715) |
| 0.2 | 0.9 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
| 0.2 | 2.9 | GO:0070063 | RNA polymerase binding(GO:0070063) |
| 0.2 | 1.1 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
| 0.2 | 1.9 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
| 0.2 | 1.9 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
| 0.2 | 0.5 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
| 0.2 | 2.0 | GO:0070182 | DNA polymerase binding(GO:0070182) |
| 0.2 | 86.0 | GO:0003682 | chromatin binding(GO:0003682) |
| 0.2 | 1.0 | GO:0016728 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
| 0.2 | 0.5 | GO:0052598 | diamine oxidase activity(GO:0052597) histamine oxidase activity(GO:0052598) methylputrescine oxidase activity(GO:0052599) propane-1,3-diamine oxidase activity(GO:0052600) |
| 0.2 | 4.5 | GO:0003951 | NAD+ kinase activity(GO:0003951) |
| 0.2 | 1.8 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
| 0.2 | 1.3 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
| 0.2 | 0.8 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
| 0.2 | 9.3 | GO:0031593 | polyubiquitin binding(GO:0031593) |
| 0.1 | 0.6 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
| 0.1 | 2.8 | GO:0048018 | receptor agonist activity(GO:0048018) |
| 0.1 | 0.6 | GO:0031699 | beta-3 adrenergic receptor binding(GO:0031699) |
| 0.1 | 3.5 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
| 0.1 | 1.1 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
| 0.1 | 0.4 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
| 0.1 | 50.9 | GO:0005096 | GTPase activator activity(GO:0005096) |
| 0.1 | 0.4 | GO:0016781 | selenide, water dikinase activity(GO:0004756) phosphotransferase activity, paired acceptors(GO:0016781) |
| 0.1 | 0.7 | GO:0016530 | metallochaperone activity(GO:0016530) |
| 0.1 | 1.9 | GO:0035497 | cAMP response element binding(GO:0035497) |
| 0.1 | 5.2 | GO:0044390 | ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
| 0.1 | 0.7 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
| 0.1 | 11.3 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
| 0.1 | 3.2 | GO:0097602 | cullin family protein binding(GO:0097602) |
| 0.1 | 0.4 | GO:0036080 | GDP-fucose transmembrane transporter activity(GO:0005457) purine nucleotide-sugar transmembrane transporter activity(GO:0036080) |
| 0.1 | 6.5 | GO:0043022 | ribosome binding(GO:0043022) |
| 0.1 | 15.9 | GO:0003714 | transcription corepressor activity(GO:0003714) |
| 0.1 | 0.4 | GO:0008456 | alpha-N-acetylgalactosaminidase activity(GO:0008456) |
| 0.1 | 1.6 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
| 0.1 | 10.8 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
| 0.1 | 0.7 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
| 0.1 | 70.6 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
| 0.1 | 0.2 | GO:0070976 | TIR domain binding(GO:0070976) |
| 0.1 | 0.7 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
| 0.1 | 5.4 | GO:0003785 | actin monomer binding(GO:0003785) |
| 0.1 | 1.7 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
| 0.1 | 2.0 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
| 0.1 | 0.7 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
| 0.1 | 0.4 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
| 0.1 | 0.5 | GO:0070034 | telomerase RNA binding(GO:0070034) |
| 0.1 | 3.9 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
| 0.1 | 0.7 | GO:0032052 | bile acid binding(GO:0032052) |
| 0.1 | 1.2 | GO:0009922 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
| 0.1 | 1.5 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
| 0.1 | 0.1 | GO:0001032 | RNA polymerase III type 3 promoter DNA binding(GO:0001032) |
| 0.1 | 2.1 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
| 0.1 | 0.5 | GO:0017070 | U6 snRNA binding(GO:0017070) |
| 0.1 | 1.0 | GO:0070739 | protein-glutamic acid ligase activity(GO:0070739) |
| 0.1 | 3.2 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
| 0.1 | 2.0 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
| 0.1 | 0.5 | GO:0004854 | xanthine dehydrogenase activity(GO:0004854) oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor(GO:0016726) |
| 0.1 | 2.7 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
| 0.1 | 1.3 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
| 0.1 | 0.9 | GO:0030331 | estrogen receptor binding(GO:0030331) |
| 0.1 | 0.2 | GO:0004637 | phosphoribosylamine-glycine ligase activity(GO:0004637) |
| 0.1 | 0.2 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
| 0.1 | 4.3 | GO:0046332 | SMAD binding(GO:0046332) |
| 0.1 | 0.4 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
| 0.1 | 0.5 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
| 0.1 | 1.0 | GO:0003746 | translation elongation factor activity(GO:0003746) |
| 0.1 | 36.2 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
| 0.1 | 0.2 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
| 0.1 | 107.3 | GO:0003677 | DNA binding(GO:0003677) |
| 0.1 | 0.3 | GO:0003883 | CTP synthase activity(GO:0003883) |
| 0.1 | 0.2 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
| 0.1 | 0.8 | GO:0051787 | misfolded protein binding(GO:0051787) |
| 0.1 | 0.3 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
| 0.1 | 0.4 | GO:0050700 | CARD domain binding(GO:0050700) |
| 0.1 | 0.8 | GO:0004017 | adenylate kinase activity(GO:0004017) |
| 0.1 | 0.6 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
| 0.1 | 2.4 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
| 0.1 | 0.3 | GO:0055106 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
| 0.1 | 0.5 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
| 0.1 | 1.2 | GO:0048487 | beta-tubulin binding(GO:0048487) |
| 0.1 | 0.3 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
| 0.1 | 0.3 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
| 0.0 | 5.4 | GO:0000149 | SNARE binding(GO:0000149) |
| 0.0 | 0.2 | GO:0004307 | ethanolaminephosphotransferase activity(GO:0004307) |
| 0.0 | 1.5 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
| 0.0 | 0.3 | GO:0016416 | carnitine O-palmitoyltransferase activity(GO:0004095) O-palmitoyltransferase activity(GO:0016416) |
| 0.0 | 0.6 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
| 0.0 | 1.4 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
| 0.0 | 0.4 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
| 0.0 | 5.3 | GO:0019887 | protein kinase regulator activity(GO:0019887) |
| 0.0 | 0.6 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
| 0.0 | 0.1 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
| 0.0 | 2.2 | GO:0003713 | transcription coactivator activity(GO:0003713) |
| 0.0 | 0.2 | GO:0030275 | LRR domain binding(GO:0030275) |
| 0.0 | 0.2 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
| 0.0 | 0.1 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
| 0.0 | 0.9 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
| 0.0 | 0.9 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
| 0.0 | 0.3 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
| 0.0 | 0.1 | GO:0015929 | hexosaminidase activity(GO:0015929) |
| 0.0 | 0.5 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
| 0.0 | 0.2 | GO:0070513 | death domain binding(GO:0070513) |
| 0.0 | 0.5 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
| 0.0 | 1.2 | GO:0008375 | acetylglucosaminyltransferase activity(GO:0008375) |
| 0.0 | 0.8 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
| 0.0 | 0.2 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
| 0.0 | 0.2 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
| 0.0 | 0.7 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
| 0.0 | 0.2 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
| 0.0 | 0.4 | GO:0015491 | cation:cation antiporter activity(GO:0015491) |
| 0.0 | 0.2 | GO:0015250 | water transmembrane transporter activity(GO:0005372) water channel activity(GO:0015250) |
| 0.0 | 0.1 | GO:0001849 | complement component C1q binding(GO:0001849) |
| 0.0 | 0.1 | GO:0034062 | DNA-directed RNA polymerase activity(GO:0003899) RNA polymerase activity(GO:0034062) |
| 0.0 | 3.1 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
| 0.0 | 1.7 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
| 0.0 | 0.1 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
| 0.0 | 0.4 | GO:0001671 | ATPase activator activity(GO:0001671) |
| 0.0 | 0.1 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
Gene overrepresentation in curated gene sets: canonical pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 4.1 | 285.3 | PID PLK1 PATHWAY | PLK1 signaling events |
| 3.7 | 69.6 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
| 3.0 | 139.2 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
| 1.8 | 82.2 | PID AURORA B PATHWAY | Aurora B signaling |
| 1.8 | 38.3 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
| 1.6 | 40.3 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
| 1.5 | 36.5 | PID ATR PATHWAY | ATR signaling pathway |
| 1.3 | 66.1 | PID FANCONI PATHWAY | Fanconi anemia pathway |
| 1.0 | 27.9 | PID AURORA A PATHWAY | Aurora A signaling |
| 1.0 | 84.6 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
| 1.0 | 56.6 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
| 0.9 | 10.3 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
| 0.9 | 18.3 | PID MYC PATHWAY | C-MYC pathway |
| 0.8 | 28.0 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
| 0.8 | 2.3 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
| 0.7 | 16.4 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
| 0.7 | 11.5 | PID ATM PATHWAY | ATM pathway |
| 0.6 | 13.0 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
| 0.5 | 7.9 | PID S1P S1P4 PATHWAY | S1P4 pathway |
| 0.4 | 28.5 | PID E2F PATHWAY | E2F transcription factor network |
| 0.4 | 3.3 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
| 0.4 | 8.4 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
| 0.3 | 12.1 | PID IL23 PATHWAY | IL23-mediated signaling events |
| 0.3 | 28.7 | PID IL4 2PATHWAY | IL4-mediated signaling events |
| 0.3 | 1.3 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
| 0.3 | 12.7 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
| 0.3 | 6.3 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
| 0.3 | 6.8 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
| 0.3 | 12.8 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
| 0.3 | 2.7 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
| 0.3 | 3.5 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
| 0.3 | 14.2 | PID RHOA PATHWAY | RhoA signaling pathway |
| 0.3 | 11.3 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
| 0.3 | 4.5 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
| 0.2 | 34.4 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
| 0.2 | 5.3 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
| 0.2 | 8.0 | PID RAS PATHWAY | Regulation of Ras family activation |
| 0.2 | 17.2 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
| 0.2 | 16.0 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
| 0.2 | 8.6 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
| 0.2 | 7.1 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
| 0.2 | 11.7 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
| 0.2 | 4.7 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
| 0.2 | 3.5 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
| 0.2 | 2.0 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
| 0.2 | 2.1 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
| 0.2 | 4.4 | PID TNF PATHWAY | TNF receptor signaling pathway |
| 0.2 | 7.8 | PID P73PATHWAY | p73 transcription factor network |
| 0.2 | 1.4 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
| 0.1 | 4.9 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
| 0.1 | 3.7 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
| 0.1 | 1.5 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
| 0.1 | 2.0 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
| 0.1 | 1.3 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
| 0.1 | 4.6 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
| 0.1 | 9.5 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
| 0.1 | 3.4 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
| 0.1 | 2.4 | PID P53 REGULATION PATHWAY | p53 pathway |
| 0.1 | 2.3 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
| 0.1 | 1.7 | PID IL1 PATHWAY | IL1-mediated signaling events |
| 0.1 | 0.4 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
| 0.1 | 5.7 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
| 0.1 | 1.5 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
| 0.1 | 1.8 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
| 0.1 | 1.9 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
| 0.1 | 0.8 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
| 0.1 | 1.6 | ST GA12 PATHWAY | G alpha 12 Pathway |
| 0.1 | 1.1 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
| 0.1 | 1.7 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
| 0.0 | 1.6 | PID CONE PATHWAY | Visual signal transduction: Cones |
| 0.0 | 1.7 | SIG CHEMOTAXIS | Genes related to chemotaxis |
| 0.0 | 0.5 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
| 0.0 | 0.6 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
| 0.0 | 0.6 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
| 0.0 | 0.4 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
| 0.0 | 1.1 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
| 0.0 | 0.3 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
| 0.0 | 0.6 | PID CDC42 PATHWAY | CDC42 signaling events |
| 0.0 | 0.4 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
Gene overrepresentation in curated gene sets: REACTOME pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 7.9 | 102.9 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
| 5.5 | 110.8 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
| 4.6 | 13.7 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
| 4.3 | 68.9 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
| 3.0 | 66.5 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
| 2.9 | 43.7 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
| 2.7 | 77.5 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
| 2.4 | 80.2 | REACTOME KINESINS | Genes involved in Kinesins |
| 2.1 | 10.5 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
| 1.9 | 38.6 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
| 1.9 | 36.2 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
| 1.8 | 165.7 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
| 1.8 | 21.4 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
| 1.6 | 18.8 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
| 1.5 | 19.0 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
| 1.4 | 15.6 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
| 1.4 | 29.2 | REACTOME PROCESSING OF CAPPED INTRONLESS PRE MRNA | Genes involved in Processing of Capped Intronless Pre-mRNA |
| 1.4 | 17.9 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
| 1.3 | 59.7 | REACTOME G1 PHASE | Genes involved in G1 Phase |
| 1.2 | 48.2 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
| 1.2 | 13.0 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
| 1.1 | 13.7 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
| 1.0 | 3.9 | REACTOME G2 M CHECKPOINTS | Genes involved in G2/M Checkpoints |
| 0.9 | 12.2 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
| 0.9 | 14.8 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
| 0.8 | 20.5 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
| 0.8 | 78.5 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
| 0.8 | 7.7 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
| 0.7 | 102.4 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
| 0.6 | 9.3 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
| 0.6 | 3.1 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
| 0.6 | 5.5 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
| 0.6 | 4.2 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
| 0.6 | 11.3 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
| 0.6 | 11.6 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
| 0.5 | 11.8 | REACTOME CHROMOSOME MAINTENANCE | Genes involved in Chromosome Maintenance |
| 0.5 | 3.7 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
| 0.5 | 15.9 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
| 0.5 | 11.4 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
| 0.5 | 9.8 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
| 0.4 | 15.5 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
| 0.4 | 28.7 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
| 0.4 | 4.3 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
| 0.4 | 9.6 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
| 0.4 | 14.9 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
| 0.4 | 12.0 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
| 0.4 | 7.1 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
| 0.4 | 6.7 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
| 0.4 | 9.3 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
| 0.4 | 6.2 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
| 0.4 | 7.4 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
| 0.3 | 9.3 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
| 0.3 | 22.1 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
| 0.3 | 14.9 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
| 0.3 | 11.9 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
| 0.3 | 8.5 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
| 0.3 | 2.9 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
| 0.2 | 8.4 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
| 0.2 | 25.2 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
| 0.2 | 1.4 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
| 0.2 | 6.3 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
| 0.2 | 10.0 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
| 0.2 | 6.4 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
| 0.2 | 3.2 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
| 0.2 | 12.0 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
| 0.2 | 4.0 | REACTOME MEIOSIS | Genes involved in Meiosis |
| 0.2 | 4.7 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
| 0.2 | 3.8 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
| 0.2 | 4.8 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
| 0.2 | 4.1 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
| 0.2 | 3.8 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
| 0.2 | 3.4 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
| 0.2 | 12.7 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
| 0.2 | 17.4 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
| 0.2 | 1.2 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
| 0.2 | 5.7 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
| 0.2 | 5.4 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
| 0.2 | 2.0 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
| 0.2 | 5.5 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
| 0.2 | 2.0 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
| 0.2 | 18.2 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
| 0.1 | 6.8 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
| 0.1 | 1.2 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
| 0.1 | 4.9 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
| 0.1 | 4.3 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
| 0.1 | 0.3 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
| 0.1 | 1.4 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
| 0.1 | 0.9 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
| 0.1 | 1.4 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
| 0.1 | 1.9 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
| 0.1 | 3.1 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
| 0.1 | 6.3 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
| 0.1 | 1.5 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
| 0.1 | 1.0 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
| 0.1 | 2.6 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
| 0.1 | 0.2 | REACTOME P75NTR SIGNALS VIA NFKB | Genes involved in p75NTR signals via NF-kB |
| 0.1 | 2.3 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
| 0.1 | 1.0 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
| 0.1 | 1.8 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
| 0.1 | 2.2 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
| 0.1 | 1.2 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
| 0.1 | 1.6 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
| 0.1 | 2.8 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
| 0.1 | 1.0 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
| 0.1 | 0.4 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
| 0.1 | 2.7 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
| 0.0 | 0.4 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
| 0.0 | 0.5 | REACTOME MITOTIC G2 G2 M PHASES | Genes involved in Mitotic G2-G2/M phases |
| 0.0 | 0.4 | REACTOME SIGNALING BY WNT | Genes involved in Signaling by Wnt |
| 0.0 | 1.1 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
| 0.0 | 1.0 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
| 0.0 | 0.6 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
| 0.0 | 0.2 | REACTOME OPSINS | Genes involved in Opsins |
| 0.0 | 0.2 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
| 0.0 | 0.2 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
| 0.0 | 1.4 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
| 0.0 | 0.2 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
| 0.0 | 0.3 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
| 0.0 | 0.1 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
| 0.0 | 0.2 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |